Moreover, administration of EPZ in breast carcinoma BT549, glioblastoma U87 and colon carcinoma HT29 cells led to the decrease in CD95L-induced caspase-8 (Fig. 6C–E) and caspase-3/7 activities (Fig. 6F–H). This evidence concerns the gene CASP8 and breast carcinoma.